European Advisory Committee Recommends Approval of Erleada for Men at Risk of Prostate Cancer Spreading
News
Janssen‘s hormone therapy Erleada (apalutamide) may soon be used in Europe for men with castration-resistant prostate cancer (CRPC) who have a high risk of their disease spreading, after the Committee for Medicinal ... Read more